GNAO1 Neurodevelopmental Disorder Pilot Grant Program

קרןCenter for Orphan Disease Research and Therapy
מדינהU.S.A.
סוגResearch Grants
תאריך אחרון03/03/2023
פקולטהLife Sciences, Medicine
תיאור

This grant aims to further progress our understanding of the disease, the available therapeutic options, and investigating strategies to establish outcome measurements.

The RFA could focus on one, or several, of the following aims to further advance GNAO1 research and therapeutic approaches:

• Novel therapeutic approaches, including, but not limited to, techniques in genome editing, RNA-based mechanisms, biologics, novel cell-based therapeutics, and development of novel therapeutic compounds, including through small molecule repurposing or screening against validated phenotypes in human cellular systems.

• Identification of short-term biomarkers that can monitor disease activity and treatment response.

• Establishment of outcome measures for future clinical trials.

• Development of therapeutic approaches in early symptomatic patients.

• Supporting pilot clinical trials, preclinical trials, or animal model trials that promote drug repurposing strategies.

• Development of a standardized evaluation criteria for clinical projects allowing uniformity of patients as well as the severity and progression of the disease.

• Development of cellular models (i.e. oligodendrocytes) for evaluation of therapeutic options to translate for clinical use.

 

 

 

Funding: $100,000 total 

Duration: 1 year

 

Research Authority due date: 23.2.23

LOI (required) due date: 3.3.23

Full proposal due date: 14.4.23

 

קבצים מצורפים
קישורלאתר
עדכון אחרוןעדכון אחרון: 07/02/2023
אוניברסיטת תל אביב עושה כל מאמץ לכבד זכויות יוצרים. אם בבעלותך זכויות יוצרים בתכנים שנמצאים פה ו/או השימוש
שנעשה בתכנים אלה לדעתך מפר זכויות, נא לפנות בהקדם לכתובת שכאן >>